Retroperitoneal Hemorrhage in Patients with COVID-19 Undergoing Hemodialysis: Three Case Reports

Hideaki Oka, Yoshito Homma, Yuki Nishino, Koichiro Suemori, Norio Sato, Yuko Sakurai, Mizuki Sekimoto, Shota Ando, Saki Iwamoto, Takaki Iwamoto, Mika Kondo, Taro Kamimura, Toshiaki Nakano, Takanari Kitazono

Research output: Contribution to journalArticlepeer-review

Abstract

A 73-year-old man receiving hemodialysis and antiplatelets was admitted with a mild case of COVID-19. Heparin was added, and iliopsoas hemorrhage developed. He was successfully treated by interventional radiology. A 76-year-old man receiving hemodialysis and antiplatelets was admitted with mild COVID-19. Heparin was added, and iliacus hemorrhage developed. Despite heparin discontinuation, he died of worsening pneumonia. A 74-year-old man undergoing hemodialysis was admitted with severe COVID-19. Gastrointestinal bleeding developed during continuous hemodiafiltration with heparin. Upon switching to nafamostat and increasing the dose, iliopsoas hemorrhage developed. Despite interventional radiology, he died of infectious complications. Attention to hemorrhagic complications is therefore needed in patients with COVID-19.

Original languageEnglish
Pages (from-to)1869-1876
Number of pages8
JournalInternal Medicine
Volume61
Issue number12
DOIs
Publication statusPublished - 2022

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Retroperitoneal Hemorrhage in Patients with COVID-19 Undergoing Hemodialysis: Three Case Reports'. Together they form a unique fingerprint.

Cite this